5I40

BRD9 in complex with Cpd1 (6-methyl-1,6-dihydro-7H-pyrrolo[2,3-c]pyridin-7-one)

5I40 の概要

• エントリーDOI: 10.2210/pdb5i40/pdb
• 分子名称: Bromodomain-containing protein 9, 1,2-ETHANEDIOL, DI(HYDROXYETHYL)ETHER, ... (5 entities in total)
• 機能のキーワード: bromodomain inhibitor epigenetics structure-based drug design, rna binding protein
• 由来する生物種: Homo sapiens (Human)
• タンパク質・核酸の鎖数: 1
• 化学式量合計: 12359.48

構造登録者

Murray, J.M. (登録日: 2016-02-11, 公開日: 2016-10-12, 最終更新日: 2024-03-06)

• 主引用文献: Crawford, T.D.,Tsui, V.,Flynn, E.M.,Wang, S.,Taylor, A.M.,Cote, A.,Audia, J.E.,Beresini, M.H.,Burdick, D.J.,Cummings, R.,Dakin, L.A.,Duplessis, M.,Good, A.C.,Hewitt, M.C.,Huang, H.R.,Jayaram, H.,Kiefer, J.R.,Jiang, Y.,Murray, J.,Nasveschuk, C.G.,Pardo, E.,Poy, F.,Romero, F.A.,Tang, Y.,Wang, J.,Xu, Z.,Zawadzke, L.E.,Zhu, X.,Albrecht, B.K.,Magnuson, S.R.,Bellon, S.,Cochran, A.G.; Diving into the Water: Inducible Binding Conformations for BRD4, TAF1(2), BRD9, and CECR2 Bromodomains.; J.Med.Chem., 59:5391-5402, 2016; PubMed: 27219867; DOI: 10.1021/acs.jmedchem.6b00264

実験手法

X-RAY DIFFRACTION (1.0402 Å)